Zobrazeno 1 - 10
of 59
pro vyhledávání: '"C. Theofanakis"'
Autor:
Alexandros Rodolakis, C Theofanakis, Angeliki Andrikopoulou, Dimitrios Haidopoulos, Michalis Liontos, Meletios A. Dimopoulos, Konstantinos Koutsoukos, Oraianthi Fiste, Anna Svarna, Nikolaos Thomakos, Flora Zagouri, Maria Kaparelou
Publikováno v:
Current Oncology
Current Oncology, Vol 28, Iss 410, Pp 4862-4873 (2021)
Volume 28
Issue 6
Pages 410-4873
Current Oncology, Vol 28, Iss 410, Pp 4862-4873 (2021)
Volume 28
Issue 6
Pages 410-4873
Uterine serous carcinoma accounts for 3–10% of endometrial cancers, but it is the most lethal histopathological subtype. The molecular characterization of endometrial carcinomas has allowed novel therapeutic approaches for these patients. We undert
Autor:
C Theofanakis, Alexandros Rodolakis, Dimitrios Haidopoulos, Nikolaos Thomakos, Anastasia Prodromidou
Publikováno v:
European Journal of Surgical Oncology. 47:1286-1291
Clear cell carcinoma of the ovary (CCOC), accounts for 5-25% of epithelial ovarian cancer (EOC) cases. A significant proportion of patients with CCOC are of reproductive age, wishing to preserve their fertility. The application of fertility sparing s
Autor:
O. Fiste, P. Iliopoulou, K. Tzannis, C. Theofanakis, A. Rouvali, C. Markellos, E. Kunadis, E. Potiri, A-M. Papanota, A. Papatheodoridi, A. Andrikopoulou, A. Svarna, M. Kaparelou, K. Koutsoukos, N. Thomakos, D. Haidopoulos, A. Rodolakis, F. Zagouri, M. Dimopoulos, M. Liontos
Publikováno v:
ESMO Open. 8:100807
Autor:
Christina Fotopoulou, Joanna Kacperczyk-Bartnik, PB Asuncion, M Lanner, A. Gil-Moreno, Kamil Zalewski, NR Gómez-Hidalgo, C Theofanakis, G Nelson, İlker Selçuk, N Bizzarri, Andrei Pletnev, U Acosta, Tanja Nikolova, Zoia Razumova, JL Sánchez Iglesias
Publikováno v:
Organization of gynaecological cancer care.
Introduction/Background* Enhanced Recovery After Surgery (ERAS) reduces complication rates after surgery, decreases length of hospital stay (LOS) and reduces costs. A correct implementation of the ERAS protocol and adherence to all ERAS items contrib
Autor:
N. Thomakos, C Theofanakis, DE Vlachos, V Theodoulidis, Dimitrios Haidopoulos, A. Rodolakis, V Pergialiotis
Publikováno v:
Organization of gynaecological cancer care.
Introduction/Background* The impact of COVID-19 pandemic caused a disruption of the healthcare systems and led to significant delays in diagnosis and treatment of gynecological cancer patients. New algorithms that aim to sustain balance between manag
Autor:
DE Vlachos, N. Thomakos, V Pergialiotis, C Theofanakis, V Theodoulidis, Dimitrios Haidopoulos, T Papalios, A. Rodolakis
Publikováno v:
Miscellaneous.
Introduction/Background* The nutritional adequacy of patients undergoing major surgery is an important prognostic indicator of survival. Studies in other surgical subspecialties highlight the importance of the nutritional status during the perioperat
Autor:
Michael Liontos, V Theodoulidis, Dimitrios Haidopoulos, V Pergialiotis, A. Rodolakis, K Trimmi, C Theofanakis, DE Vlachos, N. Thomakos
Publikováno v:
Ovarian cancer.
Introduction/Background* Management of a pelvic mass is a common cause of surgery among women. In nearly 20% of cases, such masses represent primary ovarian malignancies, treated with complete surgical staging. However, in 6-7% of cases, the ovarian
Publikováno v:
Ovarian cancer.
Introduction/Background* The application of fertility sparing surgery (FSS) in patients with clear cell ovarian carcinoma (CCOC) has been extensively criticized, even in patients with stage IA or IC disease, due to the high reported recurrence rates
Autor:
F Gaba, O Blyuss, I Rodriguez, J Dilley, YL Wan, A Saiz, Z Razumova, K Zalewski, T Nikolova, I Selcuk, N Bizzarri, C Theofanakis, M Lanner, A Pletnev, M Gurumurthy, R Manchanda
Publikováno v:
Miscellaneous.
Autor:
Argirios Rountis, N. Thomakos, V Pergialiotis, DE Vlachos, E Geramani, C Theofanakis, E Zachariou, V Theodoulidis, Dimitrios Haidopoulos, A. Rodolakis
Publikováno v:
Cervical cancer.
Introduction/Background* Cervical cancer represents the fourth most common malignancy in women, with more than half a million new cases each year worldwide. Despite HPV-based screening programs, liquid-based cytology and national vaccination programs